Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 2845.

https://doi.org/10.1182/blood-2019-122019

Published: 2019

Journal Articles

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Diego Villa, MD MPH, Laurie H Sehn, MD, Kerry J Savage, BSc, MD MSc, Cynthia L Toze, MD FRCPC, Kevin Song, MD, Wendie L den Brok, Ciara L Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 2814.

https://doi.org/10.1182/blood-2019-124217

Published: 2019

Journal Articles

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Pedro Farinha, MD PhD, Daisuke Ennishi, MD PhD, Anja Mottok, MD PhD, Susana Ben-Neriah, BSc, Barbara Meissner, PhD, Merrill Boyle, BSc, Jeffrey W. Craig, MD PhD, Graham W Slack, MD, Diego Villa, MD MPH, Kerry J Savage, BSc, MD MSc, Laurie H Sehn, MD, Ryan D. Morin, PhD, Marco A. Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 3964.

https://doi.org/10.1182/blood-2019-121943

Published: 2019

Journal Articles

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Elysha Vanderveer, MD BSc, Steven J.T. Huang, BMLSc, Helene Bruyere, MD FCCMG, Tanya Gillan, PhD FCCMG, Charles H. Li, MDFRCPC, Khaled Ramadan, MBBCH, MRCP, FRCPath, Diego Villa, MD MPH, David W. Scott, MBChB, PhD, Kerry J Savage, BSc, MD MSc, Joseph M Connors, MD, Laurie H Sehn, MD, Cynthia L Toze, MD FRCPC, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 4300.

https://doi.org/10.1182/blood-2019-125189

Published: 2019

Journal Articles

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Robert Kridel, MDMPH,PhD, Keren Isaev, MSc, Daisuke Ennishi, MD PhD, Brian Skinnider, MD, Karen Mungall, PhD, Andrew J. Mungall, PhD, Mehran Bakhtiari, MSc, Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Barbara Meissner, PhD, Susana Ben-Neriah, BSc, Merrill Boyle, BSc, Diego Villa, MD MPH, Marco A. Marra, PhD, Christian Steidl, MD, Randy D. Gascoyne, MD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 2763.

https://doi.org/10.1182/blood-2019-124235

Published: 2019

Journal Articles

Characterization of the "Immune Evasion" Phenotype of Richter Syndrome and the Implications for Immune-Checkpoint Inhibitor Therapy

Clare Gould, MBBS, Jennifer Lickiss, MSc, BSc, Yamuna Kankanige, Satwica Yerneni, MS, John Markham, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Diego Villa, MD MPH, Graham W Slack, MD, Collin Chin, MBBS, Constantine S. Tam, MBBS (Hons), MD, Stephen Lade, MBBS, FRCPA, Niles Elizabeth Nelson, BSc, MBBS, Paul J Neeson, BSc, PhD, John F. Seymour, MBBS, PhD FRACP, Michael Dickinson, MBBS,FRACP,FRCPA, David Alan Westerman, MBBS, FRCPA, FRACP, Piers Blombery, MBBS

Blood (2019) 134 (Supplement_1): 4290.

https://doi.org/10.1182/blood-2019-127800

Published: 2019

Journal Articles

Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1478.

https://doi.org/10.1182/blood-2019-129136

Published: 2019

Journal Articles

Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma

Stephen Parkin, MD, BSc, Joseph M. Connors, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Richard Klasa, MD, Alina S. Gerrie, MD, Randy D. Gascoyne, MD, Tamara Shenkier, MD, Cynthia L. Toze, MD, John D. Shepherd, MD, Kevin Song, MD, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 4345.

https://doi.org/10.1182/blood.V122.21.4345.4345

Published: 2013

Journal Articles

The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas

Jean-Michel Lavoie, MD, CM, MEng, Joseph M. Connors, MD, Diego Villa, MD, MPH, Richard Klasa, MD, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Alina S. Gerrie, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 1804.

https://doi.org/10.1182/blood.V122.21.1804.1804

Published: 2013

Journal Articles

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Amrit Kahlon, MD, Graham W. Slack, MD, Yuhua Sun, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 4390.

https://doi.org/10.1182/blood.V122.21.4390.4390

Published: 2013

Journal Articles

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Katharine He Xing, MD, Amrit Kahlon, MD, Joseph M. Connors, MD, Brian Skinnider, MD, Randy D. Gascoyne, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc, Graham W. Slack, MD, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4369.

https://doi.org/10.1182/blood.V122.21.4369.4369

Published: 2013

Journal Articles

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

Blood (2013) 122 (21): 1788.

https://doi.org/10.1182/blood.V122.21.1788.1788

Published: 2013

Journal Articles

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

Edward G. Brooks, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD, MSc, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Brian Skinnider, MD, Graham Slack, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4237.

https://doi.org/10.1182/blood.V122.21.4237.4237

Published: 2013

Journal Articles

The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

Kerry J. Savage, MD, MSc, Paul R. Yenson, MD, BSc, FRCPC, Tamara Shenkier, MD, Richard Klasa, MD, Diego Villa, MD, MPH, Ozge Goktepe, MSc, Christian Steidl, MD, Graham W. Slack, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD

Blood (2012) 120 (21): 303.

https://doi.org/10.1182/blood.V120.21.303.303

Published: 2012

Journal Articles

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Wendie-lou D. den Brok, MD, Kevin W. Song, MD, FRCPC, Hilary M. OLeary, MD, Richard Klasa, MD, Kerry J. Savage, MD MSc, Tamara Shenkier, MD, Diego Villa, MD, MPH, Graham W. Slack, MD, John D. Shepherd, MD, FRCPC, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD

Blood (2012) 120 (21): 1602.

https://doi.org/10.1182/blood.V120.21.1602.1602

Published: 2012

Journal Articles

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, MBBS FHKAM, Joseph M. Connors, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Mukesh Chhanabhai, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 96.

https://doi.org/10.1182/blood.V118.21.96.96

Published: 2011

Journal Articles

Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era

David Telio, MD, Diego Villa, MD, MPH, Tamara Shenkier, MD, Laurie H. Sehn, MD, MPH, Richard Klasa, MD, CM, King Tan, MBBS, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 780.

https://doi.org/10.1182/blood.V118.21.780.780

Published: 2011

Journal Articles

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

Muhammad Ali, MD, Tal Schechter, MD, Tony Panzarella, MSc, Diego Villa, MD, MPH, John Kuruvilla, MD, Vishal Kukreti, MD, Richard Tsang, MD, John J Doyle, MD, Michael Crump, MD

Blood (2010) 116 (21): 2402.

https://doi.org/10.1182/blood.V116.21.2402.2402

Published: 2010

NARROW

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Characterization of the "Immune Evasion" Phenotype of Richter Syndrome and the Implications for Immune-Checkpoint Inhibitor Therapy

Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma

Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma

The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only